Niagen Bioscience, Inc. (NAGE) — Cash Flow-to-Debt Ratio
Niagen Bioscience, Inc. (NAGE) has a Cash Flow-to-Debt Ratio of 0.13x as of September 2025, meaning its operating cash flow of $3.69 Million could theoretically repay 0% of its total liabilities ($27.46 Million) in one year. Check cash flow reinvestment rate of Niagen Bioscience, Inc. to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Niagen Bioscience, Inc. Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Niagen Bioscience, Inc. across 18 annual periods. Also explore how large is Niagen Bioscience, Inc.'s balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Niagen Bioscience, Inc. (2007–2024)
Year-by-year debt coverage analysis for Niagen Bioscience, Inc.. For market capitalisation and broader financial context, see NAGE market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | $12.11 Million | $22.18 Million | ▲ +103.3% |
| 2023 | 0.27x | $7.12 Million | $26.51 Million | ▲ +145.1% |
| 2022 | -0.59x | $-15.10 Million | $25.39 Million | ▲ +35.7% |
| 2021 | -0.93x | $-24.16 Million | $26.11 Million | ▼ -91.5% |
| 2020 | -0.48x | $-10.60 Million | $21.93 Million | ▲ +53.2% |
| 2019 | -1.03x | $-20.44 Million | $19.80 Million | ▲ +25.7% |
| 2018 | -1.39x | $-20.91 Million | $15.05 Million | ▼ -25.9% |
| 2017 | -1.10x | $-9.80 Million | $8.89 Million | ▼ -267.2% |
| 2016 | -0.30x | $-2.94 Million | $9.78 Million | ▼ -91.7% |
| 2015 | -0.16x | $-2.11 Million | $13.47 Million | ▲ +54.3% |
| 2014 | -0.34x | $-2.58 Million | $7.52 Million | ▲ +70.8% |
| 2013 | -1.18x | $-3.91 Million | $3.32 Million | ▲ +41.4% |
| 2012 | -2.01x | $-10.12 Million | $5.04 Million | ▼ -81.6% |
| 2011 | -1.11x | $-4.10 Million | $3.71 Million | ▲ +34.8% |
| 2010 | -1.69x | $-2.66 Million | $1.57 Million | ▼ -976.5% |
| 2009 | -0.16x | $-396.17K | $2.52 Million | ▲ +80.9% |
| 2008 | -0.82x | $-1.92 Million | $2.33 Million | ▲ +99.1% |
| 2007 | -96.21x | $-38.48K | $400.00 | — |